Purchase Order 75N93023P01368
Award Date 10/2/23
Potential Completion Date 7/3/24
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Kent, WA 98032, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $10,616.40 purchase order contract to Stemcell Technologies Inc. for cell lines. As the prime contractor, Stemcell Technologies will deliver cell lines to NIH/NIAID under the firm fixed price contract. Performance will take place in Kent, Washington over a one-year period from August 2023 through August 2024. No subcontractors or set aside designations were...
- This is a $24,924.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of a "HUMAN NK KIT, CAT#19055", which are likely specialized biological products and research tools to support immunology and infectious disease research initiatives within the Department of Health and Human...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,850.00 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of an EasySep Human Naive CD4+ T Cell Isolation Kit II. This small business set-aside contract provides specialized biological research materials to facilitate studies related to infectious diseases, immunology, and other areas...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,622.50 firm fixed price purchase order to Stemcell Technologies Inc. for cell culture medium under catalog number 2201103. Stemcell Technologies, whose parent company is also Stemcell Technologies, will deliver the requested products from its location in Kent, Washington by January 31, 2024 to support the NIH/NIAID's research efforts. No subcontractors or...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,350.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc., a foreign-owned, for-profit organization, for the provision of human cell enrichment kits. The contract has a completion date of May 31, 2019 and was awarded on May 15, 2018. This contract is not set aside for any specific business type. Stemcell Technologies Inc. is a...
- The U.S. National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services, awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract worth $14,934.75 to Stemcell Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the supply of the EASYSEP NEGATIVE HUMAN CD4 KIT, Catalog #19052. This product supports biomedical and scientific research, particularly in areas like infectious diseases,...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $24,605 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of Human Cell Enrichment Kits. This contract did not have a set-aside designation. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops specialized biological materials,...
- This is a firm fixed-price purchase order awarded to Stemcell Technologies Inc., a foreign-owned, for-profit biotechnology company, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services. The contract is for the delivery of specialized cell culture kits, including the STEMDIFF MICROGLIA DIFFERENTIATION KIT, STEMDIFF MICROGLIA MATURATION KIT, and STEMDIFF HEMATOPOETIC...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $15,645.00 Firm Fixed Price Purchase Order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the provision of HUMAN CD8 KITS. This award was not set aside for any specific business category. Stemcell Technologies Inc. is a subsidiary of the Canadian company Stemcell Technologies, which develops cell culture media, cell separation...